SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-274018
Filing Date
2020-10-22
Accepted
2020-10-22 07:23:26
Documents
128
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d92594d20f.htm 20-F 1538618
2 EX-4.15 d92594dex415.htm EX-4.15 122795
3 EX-4.16 d92594dex416.htm EX-4.16 96430
4 EX-4.17 d92594dex417.htm EX-4.17 198235
5 EX-12.1 d92594dex121.htm EX-12.1 10404
6 EX-12.2 d92594dex122.htm EX-12.2 10723
7 EX-13.1 d92594dex131.htm EX-13.1 6123
8 EX-15.1 d92594dex151.htm EX-15.1 2114
  Complete submission text file 0001193125-20-274018.txt   12886921

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kzia-20200630.xml EX-101.INS 4091177
10 XBRL TAXONOMY EXTENSION SCHEMA kzia-20200630.xsd EX-101.SCH 96295
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzia-20200630_cal.xml EX-101.CAL 44587
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzia-20200630_def.xml EX-101.DEF 310491
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzia-20200630_lab.xml EX-101.LAB 537770
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzia-20200630_pre.xml EX-101.PRE 471828
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 201251671
SIC: 2834 Pharmaceutical Preparations